20 Sep 2018
LIBERUM: Shield Therapeutics* - Norgine deal transforms the outlook
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Shield Therapeutics* - Norgine deal transforms the outlook
Shield Therapeutics Plc (STX:LON) | 1.3 0 (-7.0%) | Mkt Cap: 10.4m
- Published:
20 Sep 2018 -
Author:
Roger Franklin | Graham Doyle -
Pages:
4